Rudolf Ott
Leipzig University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rudolf Ott.
European Journal of Obstetrics & Gynecology and Reproductive Biology | 2001
Thomas Reck; Michaela Bussenius-Kammerer; Rudolf Ott; V. Müller; Ernst Beinder; Werner Hohenberger
In some 2% of the cases of the HELLP syndrome, severe spontaneous bleeding into the liver accompanied by haemorrhagic liver cell necrosis and rupture of the organ occurs and represents one of the main cause of death. On the basis of our own experience with four cases, a review of the literature is presented with particular focus on a therapeutic concept based on appropriate surgery. Within a MEDLINE search covering the period 1990-1999, the case reports of this kind of liver complication in the literature were analysed in terms of clinical course and outcome.In addition to our own four patients, a total of 49 cases with rupture of the liver were found in the literature. Despite surgical interventions, HELLP syndrome-associated liver rupture carried a mortality of 39%. Most patients died of haemorrhagic shock and organ failure. In order to improve survival, patients with ruptured liver or hepatic failure should be transferred to a centre with the necessary experience in liver surgery including liver transplantation. An interdisciplinary approach is required, including the use of temporary packing of the liver to control the bleeding, and during the further course of the condition, possibly even liver transplantation, as in one of our own cases.
Journal of Trauma-injury Infection and Critical Care | 2000
Rudolf Ott; Rainer Krämer; Peter Martus; Michaela Bussenius-Kammerer; Roman Carbon; Holger Rupprecht
BACKGROUND For the quantification of multiple injuries in children, a range of different trauma scores are available, the actual prognostic value of which has, however, not so far been investigated and compared in a group of patients. METHODS In 261 polytraumatized children and adolescents, 11 trauma scores (Abbreviated Injury Scale [AIS], Injury Severity Score [ISS], Glasgow Coma Scale [GCS], Acute Trauma Index [ATI], Shock Index [SI], Trauma Score [TS], Revised Trauma Score [RTS], Modified Injury Severity Score [MISS], Trauma and Injury Severity Score [TRISS]-Scan, Hannover Polytrauma Score [HPTS], and Pediatric Trauma Score [PTS]) were calculated, and their prognostic relevance in terms of survival, duration of intensive care treatment, hospital stay, and long-term outcome analyzed. RESULTS With a specificity of 80%, physiologic scores (TS, RTS, GCS, ATI) showed a greater accuracy (79-86% vs. 73-79%) with regard to survival prediction than did the anatomic scores (AIS, HPTS, ISS, PTS); combined forms of these two types of score (TRISS-Scan, MISS) did not provide any additional information (76-80%). Overall, the TRISS-Scan was the score that showed the highest correlation with duration of treatment and long-term outcome. Trauma scores specially conceived for use with children (PTS, MISS) failed to show any superiority vis-à-vis trauma scores in general. CONCLUSION With regard to prognostic quality and ease of use in the practical setting, TS and the TRISS-Scan are recommended for polytrauma in children and adolescents. Special pediatric scores are not necessary.
Annals of the New York Academy of Sciences | 2006
Christian A. Koch; Oliver Gimm; Alexander O. Vortmeyer; Haifa K. Al-Ali; Peter Lamesch; Rudolf Ott; Regine Kluge; Uta Bierbach; Andrea Tannapfel
Abstract: Neuroendocrine tumors are very heterogeneous, develop from a variety of tissues, and can be difficult to diagnose. Without the clinical manifestation of metastases, it is often difficult to characterize them as malignant. Even so‐called completely (R0) resected tumors can spread clinically visible metastases within a few months after initial surgery. Treatment options for neuroendocrine tumors including pheochromocytoma are limited. Molecular targeted therapies using tyrosine kinase inhibitors might prove to be helpful in patients with these tumors. In an immunohistochemical study, we examined KIT in 26 pheochromocytomas, 8 of which were malignant (3 adrenal pheochromocytomas, 5 paragangliomas). KIT expression was found in one of these 8 malignant tumors. This 2.5‐cm‐large adrenal pheochromocytoma originated from a woman with neurofibromatosis type 1 and spread into spine, skull, and lung. KIT expression could be demonstrated in 5% of tumor cells. On the basis of KIT expression immunohistochemically, we treated patients with neuroendocrine (i.e., medullary thyroid cancer) and other tumors with imatinib 400 mg per day, but without efficacy after 2 months of therapy. Similar results were shown by other investigators. Therefore, monotherapy with imatinib may not be efficacious in patients with neuroendocrine tumors that express KIT. Tyrosine kinase inhibitors such as sorafenib that targets several receptors in addition to KIT may be more efficacious in treating patients with neuroendocrine tumors.
Transplantation | 1998
Rudolf Ott; Rupprecht H; Born G; Müller; Reck T; Werner Hohenberger; Köckerling F
BACKGROUND Severe hyperbilirubinemia is known to exert multiple toxic effects. Thus, a reduction in bilirubin by use of various adsorbent columns has been reported for a variety of hepatic disorders, but no experience with liver transplant patients is available as yet. METHODS Plasma separation and bilirubin adsorption by an anion-exchange adsorbent column (BR-350) were performed in two patients with severe jaundice (total serum bilirubin > 55 mg/dl) and multiple organ failure that had developed after orthotopic liver transplantation. RESULTS The procedure resulted in an 18% to 35% reduction in total bilirubin after each session, accompanied by a remarkable clinical improvement. Both patients finally recovered and had a favorable outcome. No complications or side effects of bilirubin adsorption were observed during any of the six sessions. CONCLUSIONS Bilirubin adsorption is a safe and effective treatment. It should be considered as supportive therapy for excessive hyperbilirubinemia after liver transplantation. In selected cases, retransplantation may thus be avoided.
Transplantation | 2001
Müller; Rudolf Ott; Andrea Tannapfel; Werner Hohenberger; Reck T
Background. A preexisting thrombosis of the portal vein and the deep splanchnic bed can make it extremely difficult to reestablish the portal blood flow in orthotopic liver transplantation in man. Complete arterialization of the liver transplant, including the donor portal vein, might be a viable therapeutic option. A new rat transplantation model is described, in which the liver is completely arterialized. Methods. The outflow of the portal blood in the recipient was secured via a portocaval shunt. Hepatectomy was then performed and the liver transplant placed in orthotopic position. An interposed aortic segment was used for direct arterialization of the donor portal vein. Results. The laboratory parameters determined in the serum at the end of the observation period of 28 days revealed normal functioning of the transplant. The histological examinations showed largely normal cellular architecture, with no signs of necrosis, but incipient fibrosis. Conclusions. Using this new surgical technique in the rat liver transplantation model, long-term morphological and functional changes in a completely arterialized liver graft, and the regenerative capability of liver tissue perfused in this way, can be investigated.
Liver International | 2003
Rudolf Ott; Detlef Schuppan; Andrea Tannapfel; Christian Wittekind; Wolf Erhardt; Julia Henke; Nu Kilic; Ferdinand Köckerling; Thomas Reck; Werner Hohenberger; V. Müller
Abstract: Background: Arterialisation of the portal vein has been propagated as a technical variant in liver transplantation. However, the consequences of this unphysiological vascular supply are insufficiently known. Methods: Twenty‐seven healthy pigs were subjected to a left hemihepatectomy and divided into three groups. The first group received complete arterialisation of the portal vein (PVA). In the second group hepatic artery blood flow was also interrupted by dividing the artery (PVA/DHA). Nine animals served as controls (Group C). Results: Early mortality in the PVA/DHA group (6/9) was significantly increased in comparison with the PVA (2/9) and control (2/9) groups (P < 0.05). In the surviving animals, arterialisation (PVA and PVA/DHA) led to significantly faster hepatic regeneration in comparison with control animals, with comparable liver function and with liver size increasing to 278% and 293% vs 134% (P= 0.002) after 3 weeks, in liver … weeks. This was accompanied by enhanced hepatic expression of the proliferation markers MIB‐1(22.4% and 16.7% vs 5.9%, P = 0.002) and PCNA(86% and 68% vs 66%, P = 0.002) one week postoperation. At the same time, the number of apoptotic hepatocytes increased from 1.6% to 2.5% and 2.3% (P= 0.002). No significant difference was found in the collagen content of the liver after 3 weeks. Conclusions: Arterialisation of the portal vein promotes early and enhanced hepatic regeneration without impairing liver function. This technique may therefore be useful in split‐graft liver transplantation, where this aspect would be of particular importance.
Archive | 2006
V. Müller; D. Brummer; W. Erhardt; J. Henke; H. Kissler; Michael Bauer; Kerstin Amann; Werner Hohenberger; Rudolf Ott
Die Technik der permanenten PVA stellt eine einfache Methode dar, um den portalen Blutfluss im Transplantat sicherzustellen. Nach PVA ohne Reduktion des Blutflusses konnte ein signifikanter Anstieg der Kollagensynthese und Gehaltes im Gewebe gefunden werden. Die Regenerationsfahigkeit und Funktion der resezierten Leber bleibt nach PVA erhalten, ist jedoch nicht gesteigert. Anhand der im Rahmen dieser Studie erhobenen Befunde konnen die negativen Effekte der «Uberarterialisierung» durch eine Reduktion des Blutflusses weitgehend vermieden werden, daher sollte die permanente PVA bei der temporaren auxiliaren und der orthotopen Lebertransplantation nur in Verbindung mit einer portalen Regulierung des Blutflusses durchgefuhrt werden.
Liver | 2002
Christoph Herold; Thomas Reck; Peter Fischler; Rudolf Ott; Martin Radespiel-Troeger; Marion Ganslmayer; Werner Hohenberger; Eckhart G. Hahn; Detlef Schuppan
Transplant International | 2003
Rudolf Ott; Cathrin Böhner; Susanna Müller; Thomas Aigner; Michaela Bussenius-Kammerer; Süleyman Yedibela; Hermann J. Kissler; Werner Hohenberger; Thomas Reck; V. Müller
The Journal of Clinical Endocrinology and Metabolism | 2004
Konstanze Miehle; Andrea Tannapfel; Peter Lamesch; Gudrun Borte; Eva Schenker; Regine Kluge; Rudolf Ott; Volker Wiechmann; Martin Koch; Woubet T. Kassahun; Ralf Paschke; Christian A. Koch